Origins of the Opioid Crisis and its Enduring Impacts
Authors:
Top Cited Papers
- 13 November 2021
- journal article
- research article
- Published by Oxford University Press (OUP) in The Quarterly Journal of Economics
- Vol. 137 (2) , 1139-1179
Abstract
Overdose deaths involving opioids have increased dramatically since the 1990s, leading to the worst drug overdose epidemic in U.S. history, but there is limited empirical evidence about the initial causes. In this article, we examine the role of the 1996 introduction and marketing of OxyContin as a potential leading cause of the opioid crisis. We leverage cross-state variation in exposure to OxyContin's introduction due to a state policy that substantially limited the drug's early entry and marketing in select states. Recently unsealed court documents involving Purdue Pharma show that state-based triplicate prescription programs posed a major obstacle to sales of OxyContin and suggest that less marketing was targeted to states with these programs. We find that OxyContin distribution was more than 50% lower in “triplicate states” in the years after the drug's launch. Although triplicate states had higher rates of overdose deaths prior to 1996, this relationship flipped shortly after the launch and triplicate states saw substantially slower growth in overdose deaths, continuing even 20 years after OxyContin's introduction. Our results show that the introduction and marketing of OxyContin explain a substantial share of overdose deaths over the past two decades.Keywords
This publication has 52 references indexed in Scilit:
- Abuse-Deterrent Formulations and the Prescription Opioid Abuse Epidemic in the United StatesJAMA Psychiatry, 2015
- The Prescription Opioid and Heroin Crisis: A Public Health Approach to an Epidemic of AddictionAnnual Review of Public Health, 2015
- Comparative Politics and the Synthetic Control MethodAmerican Journal of Political Science, 2014
- Mortality Among Young Injection Drug Users in San Francisco: A 10-Year Follow-up of the UFO StudyAmerican Journal of Epidemiology, 2012
- Synthetic Control Methods for Comparative Case Studies: Estimating the Effect of California’s Tobacco Control ProgramJournal of the American Statistical Association, 2010
- The Promotion and Marketing of OxyContin: Commercial Triumph, Public Health TragedyAmerican Journal of Public Health, 2009
- The effect of FDA approval of a generic competitor to OxyContin® (oxycodone HCl controlled-release) tablets on the abuse of oxycodoneDrug and Alcohol Dependence, 2006
- Trends in Abuse of OxyContin® and Other Opioid Analgesics in the United States: 2002-2004The Journal of Pain, 2005
- Regulating Opioid Prescribing Through Prescription Monitoring Programs: Balancing Drug Diversion and Treatment of PainPain Medicine, 2004
- Addiction Rare in Patients Treated with NarcoticsNew England Journal of Medicine, 1980